Item 1A. Risk Factors.
7K characters. Original on sec.gov · Markdown
Item 1A. Risk Factors.
Except as described below, there are no material changes from risk factors as previously disclosed in our Annual Report on Form 10-K for our last fiscal year, filed with the SEC on March 29, 2022. We urge you to read the risk factors contained therein.
OUR PROPOSED TRANSACTION WITH ALBERTSONS CREATES INCREMENTAL BUSINESS, REGULATORY AND REPUTATIONAL RISKS
On October 13, 2022, we entered into a merger agreement with Albertsons Companies Inc., which sets forth the terms of our proposed transaction. The proposed transaction with Albertsons entails important risks, including, among others: the expected timing and likelihood of completion of the proposed transaction, including the timing, receipt and terms and conditions of any required governmental and regulatory clearance of the proposed transaction; the effect and terms and conditions of any potential divestitures, including those that may be imposed by regulators as a condition to the approval of the proposed transaction, and/or the separation of SpinCo (as described in the merger agreement); the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement; the outcome of any legal proceedings that have been instituted and may in the future be instituted against the parties and others following announcement of the merger agreement and proposed transaction; the inability to consummate the proposed transaction due to the failure to satisfy other conditions to complete the proposed transaction; risks that the proposed transaction disrupts our current plans and operations; the ability to identify and recognize, including on the expected timeline, the anticipated benefits of the proposed transaction, including anticipated total shareholder return (TSR), revenue and EBITDA expectations and synergies; the amount of the costs, fees, expenses and charges related to the proposed transaction; and our and Albertsons’ ability to successfully integrate our businesses and related operations, including our associates, and realize expected operations benefits, at the times and to the extent anticipated; the risk that results are different from those contained in forecasts when made; the risk that transaction and/or integration costs or dis-synergies are greater than expected, including as a result of conditions regulators put on any approvals of the transaction; the potential effect of the announcement and/or consummation of the proposed transaction on relationships, including with associates, suppliers and competitors; our ability to maintain an investment grade credit rating; the risk that management’s attention is diverted from other matters; risks related to the potential effect of general economic, political and market factors, including changes in the financial markets as a result of inflation or measures implemented to address inflation, and any epidemic, pandemic or disease outbreaks, on Kroger, Albertsons or the proposed transaction; the risk of adverse effects on the market price of our or Albertsons’s securities or on Albertsons’s or the Company’s operating results for any reason; the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement; and other risks described in our filings with the SEC.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
(c)
ISSUER PURCHASES OF EQUITY SECURITIES
| | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| | | | | | | | | | Approximate | ||
| | | | | | | | | | Dollar Value of | ||
| | | | | | | | | | Shares that May | ||
| | | | | | | | Total Number of | | Yet Be | ||
| | | | | | | | Shares Purchased | | Purchased | ||
| | | Total Number | | Average | | as Part of Publicly | | Under the Plans | |||
| | | of Shares | | Price Paid Per | | Announced Plans | | or Programs(4) | |||
| Period(1) | Purchased(2) | Share(2) | or Programs(3) | (in millions) | |||||||
| First four weeks | | | | | | | | | | | |
| August 14, 2022 to September 10, 2022 | 80,417 | $ | 48.53 | 80,417 | $ | 1,000 | | ||||
| Second four weeks | | | | | | | | | | | |
| September 11, 2022 to October 8, 2022 | 157,919 | $ | 47.54 | 115,406 | $ | 1,000 | | ||||
| Third four weeks | | | | | | | | | | | |
| October 9, 2022 to November 5, 2022 | 19,176 | $ | 44.63 | 19,176 | $ | 1,000 | | ||||
| Total | 257,512 | $ | 47.64 | 214,999 | $ | 1,000 | |
| (1) | The reported periods conform to our fiscal calendar composed of thirteen 28-day periods. The third quarter of 2022 contained three 28-day periods. |
|---|
| (2) | Includes (i) shares repurchased under the December 2021 Repurchase Program described below in (4), (ii) shares repurchased under a program announced on December 6, 1999 to repurchase common shares to reduce dilution resulting from our employee stock option and long-term incentive plans, under which repurchases are limited to proceeds received from exercises of stock options and the tax benefits associated therewith (“1999 Repurchase Program”) and (iii) 42,513 shares that were surrendered to the Company by participants under our long-term incentive plans to pay for taxes on restricted stock awards. |
|---|
| (3) | Represents shares repurchased under the December 2021 Repurchase Program and the 1999 Repurchase Program. |
|---|
| (4) | On December 30, 2021, our Board of Directors approved a $1.0 billion share repurchase program to reacquire shares via open market purchase or privately negotiated transactions, block trades, or pursuant to trades intending to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “December 2021 Repurchase Program”). The December 2021 Repurchase Program was exhausted during the third quarter of 2022. On September 9, 2022, our Board of Directors approved a $1.0 billion share repurchase program to reacquire shares via open market purchase or privately negotiated transactions, block trades, or pursuant to trades intending to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “September 2022 Repurchase Program”). The amounts shown in this column reflect the amount remaining under the September 2022 Repurchase Program as of the specified period end dates. Amounts available under the 1999 Repurchase Program are dependent upon option exercise activity. The September 2022 Repurchase Program and the 1999 Repurchase Program do not have an expiration date but may be suspended or terminated by our Board of Directors at any time. During the third quarter of 2022, we paused the September 2022 Repurchase Program to prioritize de-leveraging following the proposed merger with Albertsons. |
|---|
Previous: Item 1. Legal Proceedings. · Next: Item 6. Exhibits.